Search
Tilray Brands Inc
TLRYAdd to Watchlist
4.200USD
+0.210+5.26%
Close 07-30 16:00（ET）Quotes delayed by 15 min
553.07MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-29The current earnings forecast score of Tilray Brands Inc is 6.73, ranking 124 out of 155 in the Pharmaceuticals industry. The average price target is 18.00, with a high of 25.00 and a low of 8.50.
Analyst Rating
Based on
11
analysts
Hold
Current Rating
10.482
Target Price
+160.10%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Tilray Brands Inc
TLRY
11
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
33
Pfizer Inc
PFE
32
1
2
3
...
32
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Tilray Brands Inc's expected revenue for the next quarter?
Tilray Brands Inc's expected revenue is 259.16M.
What is Tilray Brands Inc's price target?
Analysts forecast that Tilray Brands Inc's price target is USD 18.00, with the highest forecast at USD 25.00 and the lowest forecast at USD 8.50.
How have Tilray Brands IncTLRY's recent earnings per share performed?
The market expectation was USD -0.42, while Tilray Brands IncTLRY's earnings per share (EPS) for the previous quarter was USD -0.24. EPS for the next quarter is expected at USD -0.15.
What is the analyst rating for Tilray Brands Inc?
Based on the ratings of Tilray Brands Inc's stock from 11 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.